Platelet-rich fibrin gel as an in situ bioreactor supporting serotonergic neuron survival and neural lineage gene expression in rat mesenchymal stem cells

Home/2026, Vol. 14, No. 1/Platelet-rich fibrin gel as an in situ bioreactor supporting serotonergic neuron survival and neural lineage gene expression in rat mesenchymal stem cells

ORIGINAL RESEARCH

Cell and Organ Transplantology. 2026; 14(1):e2026141192.
DOI: 10.22494/cot.v14-1.192

Platelet-rich fibrin gel as an in situ bioreactor supporting serotonergic neuron survival and neural lineage gene expression in rat mesenchymal stem cells

Usenko O.1, Khyzhnyak M.2, Vasylieva I.2, Oleksenko N.2, Chopyk N.2, Tsyubko N.2

  • 1Shalimov National Scientific Center of Surgery and Transplantology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • 2Romodanov State Institute of Neurosurgery, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine

Abstract

Platelet-derived biomaterials are increasingly used in regenerative medicine as bioactive scaffolds capable of modulating cell survival, lineage-associated molecular responses, and tissue repair. Fibrin gels enriched with platelet-derived growth factors represent a promising microenvironment for neural tissue engineering, as they may support neuronal survival and promote neural lineage-associated changes in stem cells.
Objective. To evaluate the ability of a platelet-enriched fibrin gel derived from human platelet-rich plasma to function as a bioactive three-dimensional microenvironment supporting survival and morphogenesis of serotonergic neurons and neural lineage-associated changes in mesenchymal stem cells (MSCs).
Materials and methods. A platelet-enriched fibrin gel matrix was generated from platelet-rich plasma following activation with a silica-based coagulation activator. A platelet-enriched fibrin gel matrix derived from human platelet-rich plasma served as a three-dimensional culture platform for bone marrow-derived MSCs from newborn rats and for primary serotonergic cells isolated from raphe nuclei. Cultures were maintained for up to 14 days. Serotonin production was assessed using ELISA, while expression of genes associated with serotonergic phenotype maintenance (Pet1, Nkx2-2, Tph2, Slc6a4) and neural lineage-associated molecular changes (Nes, Tubb3, Gfap, Olig2) was analyzed by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR).
Results. Raphe-derived cells cultured within the platelet-enriched fibrin gel matrix demonstrated active neurite extension and formation of neuronal networks. Maintenance of a serotonergic phenotype was supported by histochemical detection of serotonin and by persistence of Pet1, Nkx2-2, Tph2, and Slc6a4 expression during the culture period. MSCs cultured within the matrix in the presence of neuroinductive factors (retinoic acid, NGF, and BDNF) exhibited morphological features of neural-like cells and increased expression of early neural (Nes), neuronal (Tubb3), astroglial (Gfap), and oligodendroglial (Olig2) markers compared with control cultures. These findings indicate that platelet-enriched fibrin gel functions as a bioactive three-dimensional microenvironment supporting neuronal survival and neural lineage-associated molecular changes in MSCs and may serve as an in situ bioreactor-like platform for modeling neural regeneration in vitro.
Conclusions. The platelet-enriched fibrin gel matrix provided a bioactive three-dimensional microenvironment that supported survival of serotonergic cells and modulated neural marker expression in MSCs under neuroinductive conditions. These findings are consistent with neural lineage-associated molecular responses, although additional quantitative and functional validation is required to confirm mature neural differentiation.

Keywords: platelet-enriched fibrin gel; mesenchymal stem cells; serotonergic neurons; neural lineage commitment; neural tissue engineering; regenerative medicine

 


Full text PDF

1. Etulain J. Platelets in wound healing and regenerative medicine. Platelets. 2018;29(6):556-568. doi:10.1080/09537104.2018.1430357.
https://doi.org/10.1080/09537104.2018.1430357
PMid:29442539
2. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(Suppl 1):S13-S33. doi:10.1160/THS10-11-0720.
https://doi.org/10.1160/THS10-11-0720
PMid:21479340
3. Johnson PJ, Tatara A, Shiu A, Sakiyama-Elbert SE. Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing affinity-based delivery systems. J Control Release. 2010;146(2):171-178. doi:10.1016/j.jconrel.2010.05.012.
https://doi.org/10.1016/j.jconrel.2010.05.012
PMid:20493218
4. Samson SC, Khan AM, Mendoza MC. ERK signaling for cell migration and invasion. Front Mol Biosci. 2022;9:998475. doi:10.3389/fmolb.2022.998475.
https://doi.org/10.3389/fmolb.2022.998475
PMid:36262472 PMCid:PMC9573968
5. Wang M, Lin C, Jia X, Zhang L, Chen Y, Li H. HGF/c-Met signaling promotes the migration and proliferation of deer antler MSCs. Sci Rep. 2023;13:11121. doi:10.1038/s41598-023-38116-7.
https://doi.org/10.1038/s41598-023-38116-7
PMid:37429874 PMCid:PMC10333329
6. Wang X, Guan Y, Xiang S, Clark KL, Alexander PG, Lin H. Role of canonical Wnt/β-catenin pathway in regulating chondrocytic hypertrophy in mesenchymal stem cell-based cartilage tissue engineering. Front Cell Dev Biol. 2022;10:812081. doi:10.3389/fcell.2022.812081.
https://doi.org/10.3389/fcell.2022.812081
PMid:35141220 PMCid:PMC8820467
7. Zhou S. TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J Cell Biochem. 2011;112(6):1651-1660. doi:10.1002/jcb.23079.
https://doi.org/10.1002/jcb.23079
PMid:21344492 PMCid:PMC3079785
8. Saidova AA, Vorobjev IA. Lineage commitment, signaling pathways, and cytoskeleton systems in mesenchymal stem cells. Tissue Eng Part B Rev. 2020;26(1):13-25. doi:10.1089/ten.TEB.2019.0250.
https://doi.org/10.1089/ten.teb.2019.0250
PMid:31663422 PMCid:PMC12862248
9. Borroto-Escuela DO, Pérez-Alea M, Narvaez M, Tarakanov AO, Mudó G, Fuxe K. Enhancement of FGFR1 signaling in the FGFR1-5-HT1A heteroreceptor complex in midbrain raphe 5-HT neuron systems. Biochem Biophys Res Commun. 2015;463(3):180-186. doi:10.1016/j.bbrc.2015.04.133.
https://doi.org/10.1016/j.bbrc.2015.04.133
PMid:25957476
10. Werner H. The IGF1 signaling pathway: from basic concepts to therapeutic opportunities. Int J Mol Sci. 2023;24(19):14882. doi:10.3390/ijms241914882.
https://doi.org/10.3390/ijms241914882
PMid:37834331 PMCid:PMC10573540
11. Wang L, Ruan M, Bu Q, Zhao C. Signaling pathways driving MSC osteogenesis: mechanisms, regulation, and translational applications. Int J Mol Sci. 2025;26(3):1311. doi:10.3390/ijms26031311.
https://doi.org/10.3390/ijms26031311
PMid:39941080 PMCid:PMC11818554
12. Otsuka T, Mengsteab PY, Laurencin CT. Control of mesenchymal cell fate via application of FGF-8b in vitro. Stem Cell Res. 2021;51:102155. doi:10.1016/j.scr.2021.102155.
https://doi.org/10.1016/j.scr.2021.102155
PMid:33445073 PMCid:PMC8027992
13. Lee J, Henderson K, Massidda MW, Armenta-Ochoa M, Im BG, Kim J. Mechanobiological conditioning of mesenchymal stem cells for enhanced vascular regeneration. Nat Biomed Eng. 2021;5(1):89-102. doi:10.1038/s41551-020-00674-w.
https://doi.org/10.1038/s41551-020-00674-w
PMid:33483713 PMCid:PMC8875880
14. Alnasser SM, Alrobian AS, Alfayez MS, Almutairi OT, Almutairi SS, Alkeraidees TS. Pharmacological modulation of stem cell signaling pathways for therapeutic applications. Stem Cell Res Ther. 2025;16(1):327. doi:10.1186/s13287-025-04438-8.
https://doi.org/10.1186/s13287-025-04438-8
PMid:40598543 PMCid:PMC12210473
15. Luo J, Li P. Context-dependent transcriptional regulations of YAP/TAZ in stem cells and differentiation. Stem Cell Res Ther. 2022;13(1):10. doi:10.1186/s13287-021-02686-y.
https://doi.org/10.1186/s13287-021-02686-y
PMid:35012640 PMCid:PMC8751096
16. Zha K, Yang Y, Tian G, Sun Z, Yang Z, Liu S. Nerve growth factor (NGF) and NGF receptors in mesenchymal stem/stromal cells: impact on potential therapies. Stem Cells Transl Med. 2021;10(7):1008-1020. doi:10.1002/sctm.20-0290.
https://doi.org/10.1002/sctm.20-0290
PMid:33586908 PMCid:PMC8235142
17. Tzeng HH, Hsu CH, Chung TH, Lee WC, Lin CH, Wang JY. Cell signaling and differential protein expression in neuronal differentiation of bone marrow mesenchymal stem cells with hypermethylated Salvador/Warts/Hippo (SWH) pathway genes. PLoS One. 2015;10(12):e0145542. doi:10.1371/journal.pone.0145542.
https://doi.org/10.1371/journal.pone.0145542
PMid:26713735 PMCid:PMC4699852
18. Brown G. Retinoic acid receptor regulation of decision-making for cell differentiation. Front Cell Dev Biol. 2023;11:1182204. doi:10.3389/fcell.2023.1182204.
https://doi.org/10.3389/fcell.2023.1182204
PMid:37082619 PMCid:PMC10110968
19. Zhang Y, Liu Q, Sun W, Zhao M, Han J, Xu L. All-trans retinoic acid pretreatment of mesenchymal stem cells promotes HA production and activates the PI3K/AKT pathway in renal injury. Cell Commun Signal. 2024;22:1671. doi:10.1186/s12964-024-01671-1.
https://doi.org/10.1186/s12964-024-01671-1
PMid:38802835 PMCid:PMC11129434
20. Choi BY, Lee J, Kim SJ, Kim H, Lee S, Park J. Engineered mesenchymal stem cells over-expressing BDNF activate TrkB/PLCγ/AKT/ERK signaling pathways in retinoic acid-induced SH-SY5Y cells. Pharmaceutics. 2023;16(3):436. doi:10.3390/ph16030436.
https://doi.org/10.3390/ph16030436
PMid:36986535 PMCid:PMC10054459
21. Assunção-Silva RC, Gomes ED, Sousa N, Silva NA, Salgado AJ. Hydrogels and cell based therapies in spinal cord injury regeneration. Stem Cells Int. 2015;2015:948040. doi:10.1155/2015/948040.
https://doi.org/10.1155/2015/948040
PMid:26124844 PMCid:PMC4466497
22. AVMA Guidelines for the Euthanasia of Animals: 2020 Edition, p. 58
23. Jiménez-Acosta M, Hernández L, Cristerna M, Tapia-Ramírez J, Meraz-Ríos M. Review: neuronal differentiation protocols of mesenchymal stem cells. Adv Biosci Biotechnol. 2022;13:15-71. doi:10.4236/abb.2022.131002.
https://doi.org/10.4236/abb.2022.131002
24. Tsintou M, Dalamagkas K, Seifalian AM. Advances in regenerative therapies for spinal cord injury: a biomaterials approach. Neural Regen Res. 2015;10(5):726-742. doi:10.4103/1673-5374.156967.
https://doi.org/10.4103/1673-5374.156967
PMid:26109945 PMCid:PMC4468762
25. Smidt MP, van Hooft JA. Subset specification of central serotonergic neurons. Front Cell Neurosci. 2013;7:200. doi:10.3389/fncel.2013.00200.
https://doi.org/10.3389/fncel.2013.00200
26. Donovan LJ, Spencer WC, Kitt MM, Eastman BA, Lobur KJ, Deneris ES. Lmx1b is required at multiple stages to build expansive serotonergic axon architectures. eLife. 2019;8:e48788. doi:10.7554/eLife.48788.
https://doi.org/10.7554/eLife.48788
PMid:31355748 PMCid:PMC6685705
27. Sharifi M, Kamalabadi-Farahani M, Salehi M, Ebrahimi-Brough S, Alizadeh M. Recent perspectives on the synergy of mesenchymal stem cells with micro/nano strategies in peripheral nerve regeneration: a review. Front Bioeng Biotechnol. 2024;12:1401512. doi:10.3389/fbioe.2024.1401512.
https://doi.org/10.3389/fbioe.2024.1401512
PMid:39050683 PMCid:PMC11266111
28. Son B, Park S, Cho S, Kim J, Baek SH, Yoo KH. Improved neural inductivity of size-controlled 3D human embryonic stem cells using magnetic nanoparticles. Biomater Res. 2024;28:11. doi:10.34133/bmr.0011.
https://doi.org/10.34133/bmr.0011
PMid:38500782 PMCid:PMC10944702
29. Gong M, Bi Y, Jiang W, Zhang Y, Chen L, Hou N, et al. Retinoic acid receptor beta mediates all-trans retinoic acid facilitation of mesenchymal stem cells neuronal differentiation. Int J Biochem Cell Biol. 2013;45(4):866-875. doi:10.1016/j.biocel.2013.01.002.
https://doi.org/10.1016/j.biocel.2013.01.002
PMid:23318218
30. Kamińska A, Radoszkiewicz K, Rybkowska P, Wędzińska A, Sarnowska A. Interaction of neural stem cells (NSCs) and mesenchymal stem cells (MSCs) as a promising approach in brain study and nerve regeneration. Cells. 2022;11(9):1464. doi:10.3390/cells11091464.
https://doi.org/10.3390/cells11091464
PMid:35563770 PMCid:PMC9105617
31. Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in neuroregeneration. Bioengineering (Basel). 2024;11(2):112. doi:10.3390/bioengineering11020112.
https://doi.org/10.3390/bioengineering11020112
PMid:38391598 PMCid:PMC10886199
32. Zhao DZ, Wei HX, Yang YB, Yang K, Chen F, Zhang Q, et al. Advances in the research of mesenchymal stromal cells in the treatment of maxillofacial neurological disorders and the promotion of facial nerve regeneration. Mol Neurobiol. 2025;62:14407-14423. doi:10.1007/s12035-025-04981-8.
https://doi.org/10.1007/s12035-025-04981-8
PMid:40295362 PMCid:PMC12511153
33. Li XH, Xiao HX, Wang ZX, Tang XR, Yu XF, Pan YP. Platelet concentrates preconditioning of mesenchymal stem cells and combined therapies: integrating regenerative strategies for enhanced clinical applications. Cell Transplant. 2024;33:9636897241235460. doi:10.1177/09636897241235460.
https://doi.org/10.1177/09636897241235460
PMid:38506426 PMCid:PMC10956156
34. Zhang L, Yin Y, Zhang H, Wang Q, Zhao Z, Wang Y. Mesenchymal stem cells promote neurite outgrowth through neurotrophic factor secretion. Sci Rep. 2022;12:1845. doi:10.1038/s41598-022-05845-7.
35. Li X, Zhang Y, Liu Z, Chen J, Wang H. Role of mesenchymal stem cells in neuroregeneration and neuroprotection. Front Neurol. 2025;16:1472679. doi:10.3389/fneur.2025.1472679.
https://doi.org/10.3389/fneur.2025.1472679
PMid:39974358 PMCid:PMC11835705

Usenko O, Khyzhnyak M, Vasylieva I, Oleksenko N, Chopyk N, Tsyubko O. Platelet-rich fibrin gel as an in situ bioreactor supporting serotonergic neuron survival and neural lineage gene expression in rat mesenchymal stem cells. Cell Organ Transpl. 2026; 14(1):e2026141192. doi: https://doi.org/10.22494/cot.v14-1.192 

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.